Hi AllIn times like these it`s nice to get some idea of where...

Hi All

In times like these it`s nice to get some idea of where our Tech is re the others in the space. If there is some differentiation that makes ours better it makes it easier to hold the stock.

Did some ferreting around and came up with this

http://www.evaluatepharma.com/Universal/View.aspx?type=Report&id={72606152-844D-4E13-AAE6-54DFE65132E2}¶ms=%3CPARAMS%20currencyId=%220%22%3E%3CPARAM%20linkKind=%221%22%20compId=%221002%22%20name=%22%28novoskin%20bioresorbable%20temporizing%20btm%29%20matrix%22%20itemId=%2248569%22%20/%3E%3C/PARAMS%3E&more=true#&&_ViewArgs={%22_EntityType%22%3a0%2c%22_Parameters%22%3a{%22_ContextData%22%3a%22{\%22isEPVantage\%22%3afalse%2c\%22percentage\%22%3a-1%2c\%22searchWords\%22%3a\%22\%22%2c\%22sectionID\%22%3a\%22\%22%2c\%22storyID\%22%3a254979%2c\%22notSub\%22%3afalse}%22}%2c%22_Type%22%3a1}

Find the limk on Sept 08 Abbott and click on it. It involves a bioresorbable polymer Absorb that abbott are trialling for vascular problems below the knee. Abbott are also trialling a bioresorbale stent. The polymer is a Polylactide and this is one of the polymers that are mentioned for comparative purposes in the CZD investor presentation (slide 8). According to CZD the polynovo polymer is better. So I guess the areas being investgated by Abbott are possibilities for Polynovo also.

ATB

G